Pieris napi chromosome 24, ilPieNapi1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Papilionoidea; Pieridae; Pierinae; Pieris.
REFSEQ INFORMATION: The reference sequence is identical to\nFR997718.1.\nAssembly name: ilPieNapi1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/01/30. The original whole-genome shotgun project has the\naccession CAJQFT000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Pieris napi Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC125061862, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC125061862, transcript variant X1
division abnormally delayed protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 129 samples with support for all annotated introns
division abnormally delayed protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 128 samples with support for all annotated introns
division abnormally delayed protein isoform X1
division abnormally delayed protein isoform X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
HIG1 domain family member 1A, mitochondrial-like
serine/threonine-protein phosphatase 2A activator-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A activator-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 128 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A activator-like isoform X1
serine/threonine-protein phosphatase 2A activator-like isoform X2
beta carbonic anhydrase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
beta carbonic anhydrase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 165 samples with support for all annotated introns
uncharacterized LOC125061714, transcript variant X2
uncharacterized LOC125061714, transcript variant X3
uncharacterized LOC125061714, transcript variant X1
uncharacterized LOC125061714, transcript variant X4
uncharacterized protein LOC125061714 isoform X2
uncharacterized protein LOC125061714 isoform X3
uncharacterized protein LOC125061714 isoform X1
uncharacterized protein LOC125061714 isoform X4
probable multidrug resistance-associated protein lethal(2)03659
growth hormone-regulated TBC protein 1-A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
mitochondrial import inner membrane translocase subunit TIM14
choline-phosphate cytidylyltransferase B-like, transcript variant X3
choline-phosphate cytidylyltransferase B-like, transcript variant X1
choline-phosphate cytidylyltransferase B-like isoform X1
choline-phosphate cytidylyltransferase B-like isoform X3
choline-phosphate cytidylyltransferase B-like, transcript variant X2
choline-phosphate cytidylyltransferase B-like isoform X2
uncharacterized LOC125061697, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC125061697, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
uncharacterized LOC125061696, transcript variant X2
uncharacterized LOC125061696, transcript variant X1
uncharacterized protein LOC125061696 isoform X1
uncharacterized protein LOC125061696 isoform X2
uncharacterized LOC125061697, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
uncharacterized LOC125061697, transcript variant X2
uncharacterized LOC125061697, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized LOC125061697, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 154 samples with support for all annotated introns
prostatic acid phosphatase-like, transcript variant X1
prostatic acid phosphatase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 161 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51
transient receptor potential cation channel subfamily V member 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125061913, transcript variant X2
uncharacterized LOC125061913, transcript variant X1
uncharacterized protein LOC125061913 isoform X2
uncharacterized protein LOC125061913 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 98 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
protein kinase C-binding protein 1-like, transcript variant X2
protein kinase C-binding protein 1-like, transcript variant X3
protein kinase C-binding protein 1-like, transcript variant X1
protein kinase C-binding protein 1-like isoform X2
protein kinase C-binding protein 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 129 samples with support for all annotated introns
uncharacterized serine-rich protein C215.13-like
YTH domain-containing family protein 3, transcript variant X4
YTH domain-containing family protein 3, transcript variant X5
YTH domain-containing family protein 3, transcript variant X3
YTH domain-containing family protein 3, transcript variant X2
YTH domain-containing family protein 3, transcript variant X1
YTH domain-containing family protein 1 isoform X1
YTH domain-containing family protein 3 isoform X2
YTH domain-containing family protein 1 isoform X3
YTH domain-containing family protein 1 isoform X4
YTH domain-containing family protein 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 77 samples with support for all annotated introns
para-nitrobenzyl esterase-like, transcript variant X2
para-nitrobenzyl esterase-like, transcript variant X1
para-nitrobenzyl esterase-like isoform X2
para-nitrobenzyl esterase-like isoform X1
cholinesterase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
cholinesterase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
cholinesterase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
peptidyl-prolyl cis-trans isomerase NIMA-interacting 4, transcript variant X2
peptidyl-prolyl cis-trans isomerase NIMA-interacting 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase NIMA-interacting 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 96 samples with support for all annotated introns
transcription termination factor 5, mitochondrial-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 150 samples with support for all annotated introns
transcription termination factor 5, mitochondrial-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 151 samples with support for all annotated introns
transcription termination factor 5, mitochondrial-like isoform X1
transcription termination factor 5, mitochondrial-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 132 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125061739, transcript variant X3
uncharacterized LOC125061739, transcript variant X2
uncharacterized LOC125061739, transcript variant X6
uncharacterized LOC125061739, transcript variant X4
uncharacterized LOC125061739, transcript variant X5
uncharacterized protein LOC125061739 isoform X3
uncharacterized protein LOC125061739 isoform X2
uncharacterized protein LOC125061739 isoform X4
uncharacterized LOC125061739, transcript variant X1
uncharacterized protein LOC125061739 isoform X1
zinc finger MYM-type protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
zinc finger MYM-type protein 1-like isoform X2
zinc finger MYM-type protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
zinc finger MYM-type protein 5-like isoform X1
serine/threonine-protein kinase mig-15, transcript variant X1
serine/threonine-protein kinase mig-15, transcript variant X4
serine/threonine-protein kinase mig-15, transcript variant X5
serine/threonine-protein kinase mig-15, transcript variant X7
serine/threonine-protein kinase mig-15, transcript variant X2
serine/threonine-protein kinase mig-15, transcript variant X6
serine/threonine-protein kinase mig-15, transcript variant X3
serine/threonine-protein kinase mig-15 isoform X1
serine/threonine-protein kinase mig-15 isoform X4
serine/threonine-protein kinase mig-15 isoform X5
serine/threonine-protein kinase mig-15 isoform X7
serine/threonine-protein kinase mig-15 isoform X2
serine/threonine-protein kinase mig-15 isoform X6
serine/threonine-protein kinase mig-15 isoform X3
uncharacterized LOC125061936, transcript variant X2
uncharacterized LOC125061936, transcript variant X1
uncharacterized LOC125061820, transcript variant X1
uncharacterized LOC125061820, transcript variant X2
basic salivary proline-rich protein 2-like, transcript variant X1
basic salivary proline-rich protein 2-like, transcript variant X2
basic salivary proline-rich protein 2-like isoform X1
basic salivary proline-rich protein 2-like isoform X2
very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase hpo-8
uncharacterized LOC125061929, transcript variant X1
uncharacterized LOC125061929, transcript variant X2
uncharacterized protein LOC125061929 isoform X1
uncharacterized protein LOC125061929 isoform X2
potassium voltage-gated channel unc-103, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
potassium voltage-gated channel unc-103, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
potassium voltage-gated channel unc-103, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel unc-103 isoform X2
potassium voltage-gated channel unc-103 isoform X1
ATP-binding cassette sub-family C member 4-like
ATP-binding cassette subfamily C member 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ATP-binding cassette subfamily C member 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
ATP-binding cassette subfamily C member 4-like
uncharacterized LOC125061763, transcript variant X1
uncharacterized protein LOC125061763 isoform X1
uncharacterized LOC125061763, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC125061763 isoform X2
ATP-binding cassette sub-family C member 4, transcript variant X1
ATP-binding cassette sub-family C member 4, transcript variant X2
ATP-binding cassette sub-family C member 4 isoform X1
ATP-binding cassette sub-family C member 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger matrin-type protein 4-like, transcript variant X3
zinc finger matrin-type protein 4-like, transcript variant X2
zinc finger matrin-type protein 4-like, transcript variant X1
uncharacterized protein LOC125061775 isoform X2
uncharacterized protein LOC125061775 isoform X1
zinc finger matrin-type protein 4-like isoform X3
putative leucine-rich repeat-containing protein DDB_G0290503, transcript variant X1
putative leucine-rich repeat-containing protein DDB_G0290503, transcript variant X2
golgin subfamily A member 4-like isoform X1
putative leucine-rich repeat-containing protein DDB_G0290503 isoform X2
DNA replication complex GINS protein SLD5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 167 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 105 samples with support for all annotated introns
RE1-silencing transcription factor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
RE1-silencing transcription factor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 149 samples with support for all annotated introns
RE1-silencing transcription factor-like isoform X2
RE1-silencing transcription factor-like isoform X1
multiple C2 and transmembrane domain-containing protein-like, transcript variant X1
multiple C2 and transmembrane domain-containing protein-like isoform X1
multiple C2 and transmembrane domain-containing protein-like, transcript variant X2
multiple C2 and transmembrane domain-containing protein-like isoform X2
multiple C2 and transmembrane domain-containing protein-like, transcript variant X3
multiple C2 and transmembrane domain-containing protein-like isoform X3
probable Golgi SNAP receptor complex member 2
EF-hand domain-containing protein 1-like
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
microsomal glutathione S-transferase 1-like
pseudouridine-5'-phosphate glycosidase, transcript variant X1
pseudouridine-5'-phosphate glycosidase, transcript variant X3
pseudouridine-5'-phosphate glycosidase, transcript variant X2
pseudouridine-metabolizing bifunctional protein C1861.05 isoform X1
pseudouridine-5'-phosphate glycosidase isoform X3
pseudouridine-5'-phosphate glycosidase isoform X2
CD63 antigen-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CD63 antigen-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
transcription termination factor 5, mitochondrial-like
succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
uncharacterized LOC125061893, transcript variant X1
uncharacterized LOC125061893, transcript variant X2
putative ATP-dependent RNA helicase Pl10, transcript variant X1
putative ATP-dependent RNA helicase Pl10, transcript variant X2
putative ATP-dependent RNA helicase Pl10 isoform X1
putative ATP-dependent RNA helicase Pl10 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
transfer RNA serine (anticodon GCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
glycerophosphodiester phosphodiesterase GDPD6-like, transcript variant X1
glycerophosphodiester phosphodiesterase GDPD6-like, transcript variant X2
glycerophosphodiester phosphodiesterase GDPD6-like isoform X1
glycerophosphodiester phosphodiesterase GDPD6-like isoform X2
glycerophosphodiester phosphodiesterase GDPD6-like
beta-1,3-galactosyltransferase 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
beta-1,3-galactosyltransferase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X1
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X2
probable multidrug resistance-associated protein lethal(2)03659 isoform X1
probable multidrug resistance-associated protein lethal(2)03659 isoform X2
dynein regulatory complex protein 9-like
diuretic hormone 45, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
diuretic hormone 45, transcript variant X2
diuretic hormone 45, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
protein O-mannosyl-transferase TMTC4, transcript variant X1
protein O-mannosyl-transferase TMTC4, transcript variant X3
protein O-mannosyl-transferase TMTC4 isoform X1
protein O-mannosyl-transferase TMTC4 isoform X3
protein O-mannosyl-transferase TMTC4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 128 samples with support for all annotated introns
protein O-mannosyl-transferase TMTC4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 77 samples with support for all annotated introns
uncharacterized LOC125061797, transcript variant X1
uncharacterized LOC125061797, transcript variant X2
uncharacterized protein LOC125061797 isoform X1
uncharacterized protein LOC125061797 isoform X2
decapping nuclease DXO homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
decapping nuclease DXO homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
uncharacterized LOC125061869, transcript variant X1
uncharacterized LOC125061869, transcript variant X2
uncharacterized LOC125061869, transcript variant X3
uncharacterized protein LOC125061869 isoform X1
uncharacterized protein LOC125061869 isoform X2
cyclic nucleotide-gated cation channel alpha-3, transcript variant X6
cyclic nucleotide-gated cation channel alpha-3, transcript variant X4
cyclic nucleotide-gated cation channel alpha-3, transcript variant X1
cyclic nucleotide-gated cation channel alpha-3, transcript variant X5
cyclic nucleotide-gated cation channel alpha-3, transcript variant X2
cyclic nucleotide-gated cation channel alpha-3, transcript variant X3
cyclic nucleotide-gated cation channel alpha-3 isoform X6
cyclic nucleotide-gated cation channel alpha-3 isoform X4
cyclic nucleotide-gated cation channel alpha-3 isoform X1
cyclic nucleotide-gated cation channel alpha-3 isoform X5
cyclic nucleotide-gated cation channel alpha-3 isoform X2
cyclic nucleotide-gated cation channel alpha-3 isoform X3
flap endonuclease GEN, transcript variant X2
flap endonuclease GEN, transcript variant X3
flap endonuclease GEN, transcript variant X1
flap endonuclease GEN, transcript variant X4
methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial
transfer RNA alanine (anticodon AGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC125061949, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 80 samples with support for all annotated introns
uncharacterized LOC125061949, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
uncharacterized protein LOC125061949 isoform X2
uncharacterized protein LOC125061949 isoform X1
probable serine incorporator, transcript variant X1
probable serine incorporator, transcript variant X2
probable serine incorporator, transcript variant X4
probable serine incorporator, transcript variant X3
probable serine incorporator, transcript variant X5
isocitrate dehydrogenase [NADP] cytoplasmic-like, transcript variant X2
isocitrate dehydrogenase [NADP] cytoplasmic-like, transcript variant X1
isocitrate dehydrogenase [NADP] cytoplasmic-like
NAD(P) transhydrogenase, mitochondrial-like, transcript variant X1
NAD(P) transhydrogenase, mitochondrial-like, transcript variant X3
NAD(P) transhydrogenase, mitochondrial-like, transcript variant X2
NAD(P) transhydrogenase, mitochondrial-like
extended synaptotagmin-2-B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
extended synaptotagmin-2-B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 165 samples with support for all annotated introns
extended synaptotagmin-2-B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 163 samples with support for all annotated introns
extended synaptotagmin-2-B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
extended synaptotagmin-2-B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 107 samples with support for all annotated introns
E3 SUMO-protein ligase RanBP2-like, transcript variant X2
E3 SUMO-protein ligase RanBP2-like, transcript variant X1
E3 SUMO-protein ligase RanBP2-like isoform X2
E3 SUMO-protein ligase RanBP2-like isoform X1
transcription initiation factor TFIID subunit 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 138 samples with support for all annotated introns
transcription initiation factor TFIID subunit 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 115 samples with support for all annotated introns
transcription initiation factor TFIID subunit 6-like isoform X1
transcription initiation factor TFIID subunit 6-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
UDP-glucose:glycoprotein glucosyltransferase
transport and Golgi organization protein 11, transcript variant X2
transport and Golgi organization protein 11, transcript variant X1
transport and Golgi organization protein 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
chymotrypsin-2-like, transcript variant X1
chymotrypsin-2-like, transcript variant X2
chymotrypsin-2-like, transcript variant X4
chymotrypsin-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 129 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 14
glutamate--cysteine ligase catalytic subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 165 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
probable ubiquitin carboxyl-terminal hydrolase FAF
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
tRNA-uridine aminocarboxypropyltransferase 1
F-box-like/WD repeat-containing protein TBL1X
methionine-R-sulfoxide reductase B1, transcript variant X1
methionine-R-sulfoxide reductase B1, transcript variant X2
methionine-R-sulfoxide reductase B1 isoform X1
methionine-R-sulfoxide reductase B1 isoform X2
serine/threonine-protein kinase Pak, transcript variant X4
serine/threonine-protein kinase Pak, transcript variant X3
serine/threonine-protein kinase Pak, transcript variant X2
serine/threonine-protein kinase Pak, transcript variant X1
serine/threonine-protein kinase Pak, transcript variant X5
serine/threonine-protein kinase Pak isoform X4
serine/threonine-protein kinase Pak isoform X3
serine/threonine-protein kinase Pak isoform X2
serine/threonine-protein kinase Pak isoform X1
serine/threonine-protein kinase Pak isoform X5
GRIP and coiled-coil domain-containing protein 2-like
elongation factor 1-alpha 2, transcript variant X3
elongation factor 1-alpha 2, transcript variant X2
elongation factor 1-alpha 2, transcript variant X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1-like
TAR DNA-binding protein 43-like, transcript variant X3
TAR DNA-binding protein 43-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
TAR DNA-binding protein 43-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 107 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
facilitated trehalose transporter Tret1-2 homolog, transcript variant X1
facilitated trehalose transporter Tret1-2 homolog, transcript variant X2
facilitated trehalose transporter Tret1-2 homolog isoform X1
facilitated trehalose transporter Tret1-2 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
GAS2-like protein 3, transcript variant X2
GAS2-like protein 3, transcript variant X3
GAS2-like protein 3, transcript variant X4
GAS2-like protein 3, transcript variant X1
eukaryotic translation initiation factor 2D
serine/threonine-protein kinase Nek2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
kinesin-like protein Klp68D, transcript variant X2
kinesin-like protein Klp68D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
vacuolar protein sorting-associated protein 26C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
transmembrane protein 131 homolog, transcript variant X1
transmembrane protein 131 homolog isoform X1
transmembrane protein 131 homolog, transcript variant X2
transmembrane protein 131 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 156 samples with support for all annotated introns
lutropin-choriogonadotropic hormone receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
lutropin-choriogonadotropic hormone receptor isoform X1
lutropin-choriogonadotropic hormone receptor, transcript variant X2
leucine-rich repeat-containing G-protein coupled receptor 6 isoform X2
probable asparagine--tRNA ligase, mitochondrial
pre-mRNA cleavage complex 2 protein Pcf11, transcript variant X2
pre-mRNA cleavage complex 2 protein Pcf11, transcript variant X1
pre-mRNA cleavage complex 2 protein Pcf11 isoform X2
pre-mRNA cleavage complex 2 protein Pcf11 isoform X1
uncharacterized LOC125061688, transcript variant X2
uncharacterized LOC125061688, transcript variant X3
uncharacterized LOC125061688, transcript variant X1
uncharacterized protein LOC125061688 isoform X2
uncharacterized protein LOC125061688 isoform X3
uncharacterized protein LOC125061688 isoform X1
uncharacterized LOC125061688, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized protein LOC125061688 isoform X4
putative oxidoreductase GLYR1 homolog, transcript variant X1
putative oxidoreductase GLYR1 homolog, transcript variant X2
putative oxidoreductase GLYR1 homolog, transcript variant X3
putative oxidoreductase GLYR1 homolog isoform X1
putative oxidoreductase GLYR1 homolog isoform X2
putative oxidoreductase GLYR1 homolog isoform X3
immunoglobulin domain and leucine-rich repeat-containing protein 2-like, transcript variant X3
immunoglobulin domain and leucine-rich repeat-containing protein 2-like, transcript variant X2
immunoglobulin domain and leucine-rich repeat-containing protein 2-like, transcript variant X1
immunoglobulin domain and leucine-rich repeat-containing protein 2-like
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
rho GTPase-activating protein 6, transcript variant X3
rho GTPase-activating protein 6 isoform X3
rho GTPase-activating protein 6, transcript variant X1
rho GTPase-activating protein 6, transcript variant X2
uncharacterized protein LOC125061813 isoform X1
uncharacterized protein LOC125061813 isoform X2
rho GTPase-activating protein 6, transcript variant X4
rho GTPase-activating protein 6 isoform X4
uncharacterized LOC125061826, transcript variant X2
uncharacterized LOC125061826, transcript variant X1
uncharacterized protein LOC125061826 isoform X1
uncharacterized protein LOC125061826 isoform X2
endoplasmic reticulum-Golgi intermediate compartment protein 2
uncharacterized LOC125061914, transcript variant X1
uncharacterized protein LOC125061914 isoform X1
uncharacterized LOC125061914, transcript variant X2
uncharacterized LOC125061914, transcript variant X4
uncharacterized LOC125061914, transcript variant X5
uncharacterized LOC125061914, transcript variant X3
uncharacterized protein LOC125061914 isoform X2
uncharacterized LOC125061914, transcript variant X6
uncharacterized protein LOC125061914 isoform X3
protein Fe65 homolog, transcript variant X1
protein Fe65 homolog, transcript variant X3
protein Fe65 homolog, transcript variant X2
protein Fe65 homolog, transcript variant X6
protein Fe65 homolog, transcript variant X4
protein Fe65 homolog, transcript variant X7
protein Fe65 homolog, transcript variant X5
protein Fe65 homolog, transcript variant X8
protein Fe65 homolog, transcript variant X10
protein Fe65 homolog, transcript variant X9
protein ALP1-like, transcript variant X1
protein ALP1-like, transcript variant X2
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like isoform X2
leucine-rich repeat-containing protein 24-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein